Oramed Pharmaceuticals
ORMP
ORMP
75 hedge funds and large institutions have $51.2M invested in Oramed Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
66% more call options, than puts
Call options by funds: $4.82M | Put options by funds: $2.91M
8.03% more ownership
Funds ownership: 4.21% → 12.24% (+8%)
Holders
75
Holding in Top 10
–
Calls
$4.82M
Puts
$2.91M
Top Buyers
| 1 | +$15.9M | |
| 2 | +$4.71M | |
| 3 | +$2.82M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.69M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.67M |
Top Sellers
| 1 | -$800K | |
| 2 | -$772K | |
| 3 | -$755K | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$533K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$122K |